CONE-ROD DYSTROPHY 19
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
CONE-ROD DYSTROPHY 19
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
CONE-ROD DYSTROPHY 19
|
0.700 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Retinal Dystrophies
|
0.110 |
Biomarker
|
group |
HPO |
|
|
|
Cone-Rod Dystrophies
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Color vision defect
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Nyctalopia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Retinitis Pigmentosa
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Photophobia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Encephaloclastic Proliferative Vasculopathy
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Abnormality of retinal pigmentation
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Visual Impairment
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Juvenile-Onset Still Disease
|
0.300 |
Biomarker
|
disease |
CTD_human |
Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.
|
19565504 |
2009 |
Juvenile arthritis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.
|
19565504 |
2009 |
Juvenile psoriatic arthritis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.
|
19565504 |
2009 |
Polyarthritis, Juvenile, Rheumatoid Factor Negative
|
0.300 |
Biomarker
|
disease |
CTD_human |
Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.
|
19565504 |
2009 |
Polyarthritis, Juvenile, Rheumatoid Factor Positive
|
0.300 |
Biomarker
|
disease |
CTD_human |
Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.
|
19565504 |
2009 |
Malignant Neoplasms
|
0.020 |
AlteredExpression
|
group |
BEFREE |
Those cancers with the greatest apparent changes in STAMP mRNA were pursued in cultured cancer cell lines.
|
20374646 |
2010 |
Primary malignant neoplasm
|
0.020 |
AlteredExpression
|
group |
BEFREE |
Those cancers with the greatest apparent changes in STAMP mRNA were pursued in cultured cancer cell lines.
|
20374646 |
2010 |
ovarian neoplasm
|
0.010 |
Biomarker
|
disease |
BEFREE |
These preliminary findings suggest that further studies of STAMP in ovarian cancer may yield insight into ovarian cancer proliferation and may be useful in the development of biomarker panels.
|
20374646 |
2010 |
Malignant neoplasm of ovary
|
0.010 |
Biomarker
|
disease |
BEFREE |
These preliminary findings suggest that further studies of STAMP in ovarian cancer may yield insight into ovarian cancer proliferation and may be useful in the development of biomarker panels.
|
20374646 |
2010 |
Carcinoma, Ovarian Epithelial
|
0.010 |
Biomarker
|
disease |
BEFREE |
These preliminary findings suggest that further studies of STAMP in ovarian cancer may yield insight into ovarian cancer proliferation and may be useful in the development of biomarker panels.
|
20374646 |
2010 |
Malignant Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
Here, we review the current biology of the STAMP proteins and how they may be implicated in disease states including cancer and metabolic syndrome.
|
20924965 |
2010 |
Primary malignant neoplasm
|
0.020 |
Biomarker
|
group |
BEFREE |
Here, we review the current biology of the STAMP proteins and how they may be implicated in disease states including cancer and metabolic syndrome.
|
20924965 |
2010 |
Metabolic Syndrome X
|
0.010 |
Biomarker
|
disease |
BEFREE |
Here, we review the current biology of the STAMP proteins and how they may be implicated in disease states including cancer and metabolic syndrome.
|
20924965 |
2010 |